Fuchs' Endothelial Corneal Dystrophy clinical trials at University of California Health
1 research study open to eligible people
Study to Investigate the Safety and Efficacy of K-321 in Patients With Fuchs Endothelial Corneal Dystrophy (FECD) Following Descemetorhexis
open to eligible people ages 18 years and up
The objective of this study is to investigate the effect of K-321 in patients with Fuchs endothelial corneal dystrophy (FECD) after descemetorhexis.
at UC Davis UCLA